• Summary of FDA Advertising and Promotion Enforcement Activities - April 2011
  • June 17, 2011 | Authors: Scott Cunningham; Scott D. Danzis; Michael S. Labson; Erika Lietzan
  • Law Firm: Covington & Burling LLP - Washington Office
  • This e-alert is part of a monthly series of e-alerts summarizing publicly-available FDA enforcement letters (i.e., warning letters and untitled letters) relating to the advertising and promotion of drugs, biologics, and medical devices. In April 2011, FDA’s Division of Drug Marketing, Advertising, and Communications (DDMAC) posted the following two enforcement letters on its website: